Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | QPCT | Q16769 | 1/20 | 0.38 |
| ▸ | QPCTL | Q9NXS2 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | MDM2 | Q00987 | 16/20 | 0.35 |
| ▸ | TP53 | P04637 | 10/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | METAP2 | P50579 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24394591 | 1.00 | QPCT (0.38) | QPCTQPCTLL3MBTL1MDM2TP53 | |
| SCHEMBL29565225 | 0.81 | QPCT (0.40) | QPCTQPCTLMDM2TP53CYP1A2 | |
| SCHEMBL22869317 | 0.81 | QPCT (0.40) | QPCTQPCTLMDM2TP53CYP1A2 | |
| SCHEMBL25840630 | 0.81 | QPCT (0.34) | QPCTQPCTLMDM2TP53CYP1A2 | |
| SCHEMBL29565730 | 0.79 | PLAU (0.38) | QPCTQPCTLL3MBTL1MDM2TP53 | |
| SCHEMBL24394615 | 0.79 | PLAU (0.38) | QPCTQPCTLL3MBTL1MDM2TP53 | |
| SCHEMBL24394484 | 0.77 | HSD11B1 (0.33) | QPCTQPCTLMDM2TP53CYP1A2 | |
| SCHEMBL29564739 | 0.77 | HSD11B1 (0.33) | QPCTQPCTLMDM2TP53CYP1A2 | |
| SCHEMBL24300631 | 0.77 | MDM2 (0.41) | MDM2TP53 | |
| SCHEMBL28728598 | 0.76 | NT5E (0.36) | QPCTQPCTLMDM2TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022090711-A1 | COMPOUNDS AS CD73 INHIBITORS | AdoRx Therapeutics Limited (GB) | 2022-05-05 | — | — | WO | disclosed |